Elling v. Mesa Biotech, Inc.

District Court, D. New Mexico·Decided October 5, 2020·No. 1:19-cv-00547·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF NEW MEXICO

JOHN ELLING,

Plaintiff, v. 1:19-cv-00547-LF-SCY

MESA BIOTECH, INC., MESA TECH INTERNATIONAL, INC., HONG CAI, and ROBERT BRUCE CARY, a/k/a R. BRUCE CARY, a/k/a ROBERT CARY,

Defendants.

MEMORANDUM OPINION AND ORDER DENYING PLAINTIFF JOHN ELLING’S RULE 60(b) MOTION

THIS MATTER comes before the Court on Plaintiff John Elling’s Rule 60(b) Motion, filed July 17, 2020. Doc. 66.1 Defendants Mesa Biotech, Inc., Mesa Tech International, Inc. (“MTI”), Hong Cai, and Robert Bruce Cary filed their response in opposition to the motion on July 31, 2020, and Mr. Elling filed his reply on August 14, 2020. Docs. 69, 70. The parties consented to my conducting dispositive proceedings in this matter. See Docs. 6, 7, 9. For the following reasons, the Court DENIES Mr. Elling’s motion. I. Factual and Procedural Background This case arises out of a dispute between Plaintiff John Elling, formerly Director, President, and Chief Executive Officer of MTI, and his former colleagues, Defendants Hong Cai and Robert Bruce Cary, who now are employed at Defendant Mesa Biotech. See Doc. 1-1 (complaint) ¶¶ 6−10, 20−34; Doc. 3 (answer) ¶¶ 6–10, 20–34. Mr. Elling founded MTI with Ms.

1 All references to “Doc. ___” are to the document number in case number 1:19-cv-00547-LF- SCY (Elling I) unless otherwise noted. Cai and Mr. Cary, and all three were initial shareholders. Doc. 1-1 ¶¶ 2−4; Doc. 3 ¶¶ 2–4. MTI was a New Mexico Corporation with its principal place of business in Los Alamos County, New Mexico. See Doc. 1-1 ¶ 5; Doc. 3 ¶ 5. In October 2010, Mr. Elling agreed to resign from his positions at MTI, but he retained a portion of MTI’s stock pursuant to a written agreement. Doc. 1-1 ¶ 20; Doc. 3 ¶ 20; see also Doc. 1-1 at 10−12 (agreement between MTI and Mr. Elling).

In July 2015, MTI merged with Mesa Biotech. Doc. 1-4 at 5. By virtue of the merger, MTI was subsumed by Mesa Biotech, MTI ceased to exist, and Mr. Elling became a minority shareholder in Mesa Biotech. See Doc. 1-2 at 1–2; Doc. 1-4 at 5; Doc. 43-1 at 11. Mr. Elling claims that he first learned of MTI’s merger with Mesa Biotech in August 2018. Doc. 1-1 ¶¶ 23– 25. In October 2018 and January 2019, Mr. Elling sought to inspect MTI and Mesa Biotech’s books and records, allegedly without success. Doc. 1-1 ¶¶ 31–34. On May 7, 2019, Mr. Elling filed his complaint in this case in the First Judicial District Court of New Mexico. Doc. 1-1. Defendants removed the case to this Court on June 13, 2019. Doc. 1. In count I of his complaint, Mr. Elling claimed that Ms. Cai and Mr. Cary breached their

fiduciary duties to him. Id. ¶¶ 35−38. Count II alleged that Defendants collectively engaged in “shareholder oppression.” Id. ¶¶ 39−41. Count III alleged that MTI breached its contract with Mr. Elling, including breaching the covenant of good faith and fair dealing. Id. ¶¶ 42−46. Mr. Elling sought compensatory, punitive, and statutory damages, as well as his attorneys’ fees and costs. Id. at 8. On August 6, 2019, the Court issued a scheduling order that set a deadline of August 26, 2019 for Mr. Elling to move to amend his pleadings, a deadline of February 7, 2020 to complete all discovery, and a deadline of March 9, 2020 for all dispositive motions to be filed. Doc. 17. During discovery, the parties disagreed about the precise terms of a confidentiality order under which certain discovery would be provided, and the Court ultimately resolved those issues on December 4, 2019. Docs. 25, 26, 28, 29, 31, 32. Once the confidentiality order was in place, Mr. Elling received access to Mesa Biotech’s books and records as part of the discovery in this case. Doc. 49 at 7, ¶ 18. But Mr. Elling never sought any adjustment of any of the deadlines contained in the Court’s scheduling order, nor did he ever seek to amend his complaint. See

generally Docket, Case. No. 1:19-cv-00547-LF-SCY. On March 9, 2020, Defendants timely filed their motion for summary judgment, seeking a final judgment in their favor on all Mr. Elling’s claims. Doc. 43. The briefing on this motion was complete on April 8, 2020. See Doc. 51. Five days earlier, on April 3, 2020, Mr. Elling filed another lawsuit against Ms. Cai, Mr. Cary, Mesa Biotech, and MTI. See Doc. 1, Case No. 1:20-cv-00306-JHR-JFR (Elling II). Mr. Elling filed an amended complaint in that case on April 7, 2020 and served the defendants with the amended complaint on April 15 and 16, 2020. Docs. 3, 5–8, Case No. 1:20-cv-00306-JHR-JFR (Elling II). On April 14, 2020, Mr. Elling filed a Motion and Amended Motion for Voluntary Dismissal by Order of Court or, Alternatively, to

Consolidate this case (Elling I) with Elling II. Docs. 53, 54. On June 17, 2020, the Court granted Defendants’ motion for summary judgment and denied Mr. Elling’s motion to dismiss this case or consolidate it with Elling II. Docs. 60, 61. The Court entered final judgment the same day. Doc. 62. A month later, Mr. Elling filed this motion, asking the Court to set aside the judgment in this case because of “mistake, inadvertence, excusable neglect, or ‘any other reason that justifies relief.’” Doc. 66 at 1. More specifically, Mr. Elling argues that the Court should set aside its judgment because “[o]n July 9, 2020, Defendants filed a motion for judgment on the pleadings in Elling II on the basis of the preclusion doctrines,” and that it would be unfair if the Court in Elling II granted that motion and precluded him from litigating claims that he only found out about after he filed this lawsuit. See Doc. 66 at 3–4. Defendants oppose Mr. Elling’s motion, arguing that he has failed to establish any basis for relief under FED. R. CIV. P. 60(b). Doc. 69. For the following reasons, the Court agrees with Defendants. II. Discussion

Rule 60(b) provides in pertinent part: On motion and just terms, the court may relieve a party or its legal representative from a final judgment, order, or proceeding for the following reasons: (1) mistake, inadvertence, surprise, or excusable neglect; . . . or (6) any other reason that justifies relief. FED. R. CIV. P. 60(b). “Relief under Rule 60(b) is extraordinary and may only be granted in exceptional circumstances.” Bud Brooks Trucking, Inc. v. Bill Hodges Trucking Co., 909 F.2d 1437, 1440 (10th Cir. 1990). A. Rule 60(b)(1) “[T]he ‘mistake’ provision in Rule 60(b)(1) provides for the reconsideration of judgments only where: (1) a party has made an excusable litigation mistake or an attorney in the litigation has acted without authority from a party, or (2) where the judge has made a substantive mistake of law or fact in the final judgment or order.” Cashner v. Freedom Stores, Inc., 98 F.3d 572, 577 (10th Cir. 1996). A party’s litigation mistake does not warrant Rule 60(b)(1) relief, nor is Rule 60(b)(1) relief available for a party who simply misunderstood the legal consequences of his or her deliberate acts. Id. Rule 60(b)(1) relief also “is not available to allow a party merely to reargue an issue previously addressed by the court when the reargument merely advances new arguments or supporting facts which were available for presentation at the time of the original argument.” Id. Similarly, the “inadvertence, surprise, or excusable neglect” provisions in Rule 60(b)(1) are not intended to provide litigants an opportunity to redo their litigation strategy when it didn’t work out well the first time. See Cessna Finance Corp. v. Bielenberg Masonry Contracting, Inc., 715 F.2d 1442, 1444–47 (10th Cir.

Free access — add to your briefcase to read the full text and ask questions with AI

Elling v. Mesa Biotech, Inc., (D.N.M. 2020).

Elling v. Mesa Biotech, Inc. (Elling v. Mesa Biotech, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Cashner v. Freedom Stores, Inc.
98 F.3d 572 (Tenth Circuit, 1996)
McGraw v. Barnhart
450 F.3d 493 (Tenth Circuit, 2006)
Ruth Zimmerman v. Joe Quinn
744 F.2d 81 (Tenth Circuit, 1984)
Kile v. United States
915 F.3d 682 (Tenth Circuit, 2019)
Johnson v. Spencer
950 F.3d 680 (Tenth Circuit, 2020)
Pierce v. Cook & Co.
518 F.2d 720 (Tenth Circuit, 1975)
Pelican Production Corp. v. Marino
893 F.2d 1143 (Tenth Circuit, 1990)